Clinical Trials
Astrazeneca Says AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing...
News
Lillys neutralizing antibody bamlanivimab receives interim authorization from Health Canada as a treatment for COVID-19
Health Canada granted authorization under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 for the use...
News
FDA Authorizes Regeneron Monoclonal Antibodies for COVID-19
The U.S. FDA issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19...
News
Elsevier report highlights several new potential targets for pharmaceutical intervention to treat pancreatic cancer
Elsevier has published the findings of a new report on emerging trends in the pancreatic cancer literature. The report highlights several trending terms including XIST...
News
Fluvoxamine may prevent serious illness in COVID-19 patients
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine...
News
Warren Buffett makes big investment in US pharmaceutical firms
The investment company run by billionaire investor Warren Buffett bet $5.7bn (£4.3bn) on pharmaceutical companies during the third quarter of 2020, as the sector takes...
News
Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise
Bristol Myers Squibb announced that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.